Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencing
Authors
- Kan Yonemori (ORCID: https://orcid.org/0000-0002-7624-7611)
- Noboru Yamamoto (ORCID: https://orcid.org/0000-0002-0787-2851)
- Akito Fukuda (ORCID: https://orcid.org/0000-0002-3225-4879)
- Takashi Kubo (ORCID: https://orcid.org/0000-0003-2497-4793)
- Takafumi Koyama (ORCID: https://orcid.org/0000-0001-5807-8458)
- Yasushi Yatabe (ORCID: https://orcid.org/0000-0003-1788-559X)
- Takuji Okusaka (ORCID: https://orcid.org/0000-0003-1729-807X)
- Ken Kato (ORCID: https://orcid.org/0000-0002-1733-5072)
- Kuniko Sunami (ORCID: https://orcid.org/0000-0002-7137-5649)
- Tatsuya Yoshida (ORCID: https://orcid.org/0000-0003-4896-5824)
- Yuichiro Ohe (ORCID: https://orcid.org/0000-0002-6137-073X)
- Takaaki Mizuno (ORCID: https://orcid.org/0000-0003-4642-0345)
Institutions
- National Cancer Center (US)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1093/jjco/hyaf065
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Japan Agency for Medical Research and Development